title: Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.
abstract: We and others have recently identified mutations in the ABCA1 gene as the underlying cause of Tangier disease (TD) and of a dominantly inherited form of familial hypoalphalipoproteinemia (FHA) associated with reduced cholesterol efflux. We have now identified 13 ABCA1 mutations in 11 families (five TD, six FHA) and have examined the phenotypes of 77 individuals heterozygous for mutations in the ABCA1 gene. ABCA1 heterozygotes have decreased HDL cholesterol (HDL-C) and increased triglycerides. Age is an important modifier of the phenotype in heterozygotes, with a higher proportion of heterozygotes aged 30-70 years having HDL-C greater than the fifth percentile for age and sex compared with carriers less than 30 years of age. Levels of cholesterol efflux are highly correlated with HDL-C levels, accounting for 82% of its variation. Each 8% change in ABCA1-mediated efflux is predicted to be associated with a 0.1 mmol/l change in HDL-C. ABCA1 heterozygotes display a greater than threefold increase in the frequency of coronary artery disease (CAD), with earlier onset than unaffected family members. CAD is more frequent in those heterozygotes with lower cholesterol efflux values. These data provide direct evidence that impairment of cholesterol efflux and consequently reverse cholesterol transport is associated with reduced plasma HDL-C levels and increased risk of CAD.
authors.affiliation: Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.
authors.forename: S M
authors.initials: SM
authors.lastname: Clee
authors.forename: J J
authors.initials: JJ
authors.lastname: Kastelein
authors.forename: M
authors.initials: M
authors.lastname: van Dam
authors.forename: M
authors.initials: M
authors.lastname: Marcil
authors.forename: K
authors.initials: K
authors.lastname: Roomp
authors.forename: K Y
authors.initials: KY
authors.lastname: Zwarts
authors.forename: J A
authors.initials: JA
authors.lastname: Collins
authors.forename: R
authors.initials: R
authors.lastname: Roelants
authors.forename: N
authors.initials: N
authors.lastname: Tamasawa
authors.forename: T
authors.initials: T
authors.lastname: Stulc
authors.forename: T
authors.initials: T
authors.lastname: Suda
authors.forename: R
authors.initials: R
authors.lastname: Ceska
authors.forename: B
authors.initials: B
authors.lastname: Boucher
authors.forename: C
authors.initials: C
authors.lastname: Rondeau
authors.forename: C
authors.initials: C
authors.lastname: DeSouich
authors.forename: A
authors.initials: A
authors.lastname: Brooks-Wilson
authors.forename: H O
authors.initials: HO
authors.lastname: Molhuizen
authors.forename: J
authors.initials: J
authors.lastname: Frohlich
authors.forename: J
authors.initials: J
authors.lastname: Genest
authors.forename: M R
authors.initials: MR
authors.lastname: Hayden
mesh_terms: D064286:ATP Binding Cassette Transporter 1; D018528:ATP-Binding Cassette Transporters / Q000235:genetics* / Q000378:metabolism; D000328:Adult; D000367:Age Factors; D000368:Aged; D001692:Biological Transport; D015992:Body Mass Index; D002784:Cholesterol / Q000378:metabolism*; D008076:Cholesterol, HDL / Q000378:metabolism*; D003327:Coronary Disease / Q000235:genetics / Q000378:metabolism; D005260:Female; D006579:Heterozygote; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010641:Phenotype; D012307:Risk Factors; D012737:Sex Factors; D013631:Tangier Disease / Q000235:genetics* / Q000378:metabolism; D014280:Triglycerides / Q000378:metabolism
chemical_list: C577836:ABCA1 protein, human; D064286:ATP Binding Cassette Transporter 1; D018528:ATP-Binding Cassette Transporters; D008076:Cholesterol, HDL; D014280:Triglycerides; D002784:Cholesterol